In contrast, on week 4, reverse transcription-quantitative PCR (RT-qPCR) revealed that cerebral organoids from AD patients exhibited higher mRNA levels of mature neuronal markers including MAP2, CTIP2, and SATB2, but not GFAP, an astrocyte marker (Supplementary Fig. 3A–D). This evidence concerns the gene MAP2 and Alzheimer disease.